U-Blot® Research Grade SuptavumabCat. No. WA3580Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade SuptavumabCat. No. WA3580
U-Blot® Research Grade sunakimentCat. No. WA3579
U-Blot® Research Grade SulesomabCat. No. WA3578
U-Blot® Research Grade SugemalimabCat. No. WA3577
U-Blot® Research Grade SudubrilimabCat. No. WA3576
U-Blot® Research Grade SuciraslimabCat. No. WA3575
U-Blot® Research Grade STT-5058Cat. No. WA3574
U-Blot® Research Grade STRO-001Cat. No. WA3573
U-Blot® Research Grade StapokibartCat. No. WA3572
U-Blot® Research Grade StamulumabCat. No. WA3571
U-Blot® Research Grade SphingomabCat. No. WA3570
U-Blot® Research Grade spevatamigCat. No. WA3569